Jefferies Financial Group downgraded shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday morning, MarketBeat Ratings reports. The firm currently has $172.50 target price on the stock, up from their previous target price of $104.00. Other equities analysts also […]
Reata Pharmaceuticals (NASDAQ:RETA – Free Report) had its target price lifted by Robert W. Baird from $85.00 to $173.00 in a research note published on Monday morning, Marketbeat Ratings reports. Robert W. Baird currently has an outperform rating on the stock. RETA has been the topic of several other reports. StockNews.com initiated coverage on Reata […]
Reata Pharmaceuticals (NASDAQ:RETA – Get Free Report) was downgraded by equities research analysts at SVB Securities from an “outperform” rating to a “market perform” rating in a research report issued on Friday, FlyOnTheWall reports. Several other analysts have also commented on the stock. Stifel Nicolaus lowered shares of Reata Pharmaceuticals from a “buy” rating to […]
Reata Pharmaceuticals, Inc (NASDAQ:RETA) Given Average Recommendation of Moderate Buy by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $110.86 and last traded at $109.91, with a volume of 82894 shares traded. The stock had previously closed at $109.32. Wall Street Analyst Weigh In RETA has been […]